NLRP3 and gout: Thus, mitochondrial dysfunction may lead to changes in the mitochondrial membrane potential, release of mitochondrial ROS, and other mechanisms that activate the NLRP3 inflammasome and contribute to the release of IL-1β to promote gout progression.